|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net revenue | |||||
| Cost of sales | |||||
| Gross Margin | |||||
| Research and development | |||||
| Selling, general and administration expenses | |||||
| Operating Expenses | |||||
| Other income | |||||
| Profit of equity accounted investees with similar activity to that of the Group | |||||
| Operating Result | |||||
| Finance income | |||||
| Finance costs | |||||
| Dividends | |||||
| Financial cost of sale of trade receivables | |||||
| Change in fair value of financial instruments | |||||
| Impairment of financial assets | |||||
| Exchange differences | |||||
| Finance result | |||||
| Profit/(loss) of other equity accounted investees | |||||
| Profit before income tax | |||||
| Income tax expense | |||||
| Profit after income tax from continuing operations | |||||
| Consolidated net profit | |||||
| Profit attributable to the Parent | |||||
| Profit attributable to non-controlling interest | |||||
| Basic earnings per share (Euros) | |||||
| Diluted earnings per share (Euros) | |||||
Loading...